Enhanced Surveillance and Control of Endemic and Emerging Arboviruses in Puerto Rico
ID: 357922Type: Posted
Overview

Buyer

Centers for Disease Control and Prevention - ERA (HHS-CDC-HHSCDCERA)

Award Range

$500K - $5M

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/357922
Timeline
    Description

    The Centers for Disease Control and Prevention (CDC) has announced a Notice of Funding Opportunity (NOFO) aimed at enhancing surveillance and control of endemic and emerging arboviruses in Puerto Rico, particularly focusing on diseases such as dengue and Oropouche viruses. The initiative, coded RFA-CK-25-182, seeks to strengthen hospital and community-based research platforms, improve patient management, evaluate control strategies, and foster collaborations with local stakeholders. This funding opportunity is crucial for public health preparedness, aiming to reduce disease burden and optimize resource allocation within vulnerable communities. The total funding available is $25 million over five years, with a single award expected, and the application deadline is February 28, 2025. For more information, interested parties can contact Brian York at RYork@cdc.gov.

    Point(s) of Contact
    RYork@cdc.gov
    Files
    Title
    Posted
    RFA-CK-25-182_20241227.pdf
    The Centers for Disease Control and Prevention (CDC) issued a Notice of Funding Opportunity (NOFO) to enhance surveillance and control of endemic and emerging arboviruses in Puerto Rico, particularly focusing on diseases such as dengue and Oropouche viruses. This initiative, coded RFA-CK-25-182, has a funding allocation of $25 million over five years, aiming to strengthen hospital and community-based research platforms, improve patient management, evaluate control strategies, and foster collaborations with local stakeholders. Key objectives include enhancing hospital surveillance for acute febrile illness (AFI), conducting clinical research on arboviral diseases, maintaining a community cohort to measure infections, modernizing data management infrastructure, and improving communication with local entities. The expected outcomes involve the enrollment of participants, collection of specimens, and evaluation of diagnostic tests, with a focus on at-risk populations in Puerto Rico. Ponce Medical School Foundation at Ponce Health Sciences University is the sole eligible applicant, leveraging existing partnerships to respond to arbovirus outbreaks effectively. This initiative supports public health preparedness and aims to reduce disease burden by refining preventive strategies and optimizing resource allocation within vulnerable communities.
    Similar Opportunities
    Reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is forecasting a federal grant opportunity aimed at reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities. This initiative, structured as a cooperative agreement, focuses on three key components: enhancing healthcare provider knowledge and practices regarding Chagas disease, expanding public health surveillance for soil-transmitted helminths, and addressing other significant parasitic diseases of domestic concern. With an estimated total program funding of $10 million and an award ceiling of $1 million, the CDC anticipates making approximately seven awards, with applications due by May 2, 2025. Interested applicants can reach out to Emily Dodd at 404-639-3753 or via email at iog2@cdc.gov for further information.
    Improving HIV prevention and treatment in the Dominican Republic with a focus on priority populations under the President's Emergency Plan for AIDS Relief (PEPFAR)
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement aimed at improving HIV prevention and treatment in the Dominican Republic, particularly for priority populations such as Haitian migrants. The initiative seeks to enhance access to HIV testing and treatment, ensure retention in care, and reduce new infections through community outreach and evidence-based interventions, emphasizing collaboration with local health authorities. With an anticipated funding amount of $5.6 million for the first year, the application deadline is set for February 21, 2025, and interested applicants can reach out to Emily Dale at pepfarfoas@cdc.gov for further information.
    Building capacity along the continuum from prevention to care and treatment in the Central American region under the President's Emergency Plan for AIDS Relief (PEPFAR)
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity aimed at enhancing the capacity for HIV prevention, diagnosis, and treatment in Central American countries under the President's Emergency Plan for AIDS Relief (PEPFAR). This initiative seeks to address critical gaps in health services across El Salvador, Guatemala, Honduras, Nicaragua, and Panama, with a focus on achieving the 10-10-10 prevention objectives and the 95-95-95 care targets by 2030. Eligible applicants, including government entities, NGOs, and foreign organizations, are encouraged to develop comprehensive strategies for HIV prevention and treatment, while also enhancing the skills of healthcare workers through training and quality improvement initiatives. The application deadline is February 24, 2025, with an estimated total funding of $20 million for the first year and two awards anticipated. For further inquiries, applicants can contact Emily Dale at pepfarfoas@cdc.gov.
    Strengthening Vaccine-Preventable Disease Prevention and Response
    Centers for Disease Control - NCIRD
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity titled "Strengthening Vaccine-Preventable Disease Prevention and Response," aimed at enhancing public health systems to improve vaccine access, confidence, and demand. This initiative continues the work of existing programs such as Vaccines for Children (VFC) and Section 317, focusing on achieving high vaccination coverage and responding effectively to vaccine-preventable disease outbreaks. The total funding available for this program is $2 billion over five years, with an expected 66 awards averaging over $6 million per budget period. Applications are due by March 13, 2025, and interested parties can contact Randi Tolstyk at KKQ9@cdc.gov for further information.
    Enhancing Public Health Surveillance of Bleeding Disorders
    Centers for Disease Control - NCBDDD
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity titled "Enhancing Public Health Surveillance of Bleeding Disorders." This initiative aims to collect and utilize surveillance data from federally supported hemophilia treatment centers to inform policies and clinical practices related to hemophilia, von Willebrand disease, and other inherited bleeding disorders, ultimately seeking to reduce health complications and improve the quality of life for affected individuals. The program is critical for understanding treatment practices, monitoring health complications, and identifying causes of death among those with bleeding disorders. The estimated total program funding is $21.5 million, with individual awards ranging from $100,000 to $4.3 million. Interested applicants can reach out to Brandi Dupervil at (404) 498-6879 or via email at inm4@cdc.gov, with applications due by May 15, 2025, and an anticipated award date of August 31, 2025.
    Influenza Modeling and Forecasting
    Centers for Disease Control - NCIRD
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity titled "Influenza Modeling and Forecasting," aimed at establishing a network to enhance the CDC's capabilities in influenza modeling and forecasting. The primary objective is to improve situational awareness, inform prevention and control strategies, advance the science of influenza forecasting, and facilitate communication of results with public health officials, particularly for populations disproportionately affected by influenza. The estimated total program funding is $11,250,000, with six awards expected, and applications must be submitted electronically by January 20, 2025. For further inquiries, interested applicants can contact Justin Lushbaugh at 404.498.3036 or via email at xko0@cdc.gov.
    Monitoring, Operations Research, Evaluation of Tools for Malaria Control and Prevention in Kenya
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) has announced a Notice of Funding Opportunity (NOFO) titled "Monitoring, Operations Research, Evaluation of Tools for Malaria Control and Prevention in Kenya," aimed at enhancing malaria control and prevention efforts in Kenya. This initiative seeks to support research focused on operations research, evaluation of malaria interventions, and the advancement of laboratory capabilities to monitor malaria cases and resistance, with a strong emphasis on collaboration with the Kenya Medical Research Institute and alignment with the National Malaria Control Program. The funding available totals $13 million over five years, with individual awards ranging from $1.5 million to $3 million for successful applicants, and the application deadline is set for February 12, 2025. For further inquiries, interested parties can contact Brian York at RYork@cdc.gov.
    Support for laboratory diagnosis and monitoring to scale up and improve HIV/AIDS care and treatment services for Caribbean countries supported under the President's Emergency Plan for AIDS Relief (PEPFAR)
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity aimed at enhancing laboratory diagnosis and monitoring to improve HIV/AIDS care and treatment services in Caribbean countries under the President's Emergency Plan for AIDS Relief (PEPFAR). This cooperative agreement seeks to strengthen laboratory systems, support workforce development, and improve access to diagnostic services, particularly in Jamaica and Trinidad and Tobago, building on previous successes in laboratory accreditation and training. The program is critical for bolstering public health infrastructure in the region, with an estimated budget of $1.5 million for the first year, and applications are due by February 18, 2025. Interested applicants can reach out to Emily Dale at pepfarfoas@cdc.gov for further information.
    RFA-DD-18-000
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity titled RFA-DD-18-000, aimed at supporting health-related initiatives through cooperative agreements. Eligible applicants include states, universities, counties, small businesses, and non-profit organizations, with the program expected to award approximately 10 grants. This funding is crucial for enhancing public health efforts, although specific funding amounts have not been disclosed. Interested parties should submit their applications by October 13, 2025, and can direct inquiries to Linton C. Browning at lbrowning@cdc.gov or by phone at 770-488-2756.
    RFA-GH-18-000
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity titled RFA-GH-18-000, aimed at supporting health-related initiatives through cooperative agreements. Eligible applicants include states, universities, counties, small businesses, and non-profit organizations, with no cost-sharing or matching requirements specified. This discretionary funding opportunity is significant for enhancing public health efforts, with an expected total of 100 awards available. Interested parties should note that the application deadline is October 13, 2025, and can reach out to Linton C Browning at lbrowning@cdc.gov or by phone at 770-488-2756 for further information.